Nanocrystalline megestrol acetate with chemoradiation for advanced cervical cancer
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has spread locally but not to distant organs (stage IB3 to IVA) and surgery is not an option.
- You are scheduled to receive chemotherapy and radiation at the same time (concurrent chemoradiotherapy).
- You are at least 18 years old.
- You are in generally good health (able to care for yourself, up and about more than half the day).
- Your major organs (bone marrow, kidneys, liver, heart) are working well enough based on blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called nanocrystalline megestrol acetate to help people with advanced liver cancer who are losing weight and muscle mass. It's for those who have not yet had systemic therapy and are receiving other cancer treatments at the same time.
This study tests a special form of megestrol acetate (a medicine that can help with appetite and weight gain) in people with advanced digestive system cancers who are about to start or are already taking a type of targeted therapy called a TKI. The goal is to see if it helps with cancer-related weight loss and wasting (cachexia).
This trial tests whether a medication called megestrol acetate can help improve appetite and prevent weight loss in patients with advanced liver cancer who are receiving combination cancer treatment. The study compares the medication to placebo (inactive pill) to see if it helps patients feel hungrier and maintain their weight during treatment.
This trial tests if a new form of megestrol (a medicine that can increase appetite) helps people with advanced lung cancer who are losing weight. It is for patients who have not yet received chemotherapy for their cancer and are at risk of malnutrition.
This trial tests whether a medicine called megestrol acetate can help improve appetite and weight in people with advanced lung cancer who are malnourished. It's for those who haven't had chemotherapy for their advanced cancer yet.
This study tests whether a special form of megestrol acetate (a medicine used to help with weight and appetite) can improve outcomes when given alongside standard chemotherapy and radiation for people with stage III non-small cell lung cancer. It is for patients who are not overweight and who are not already using other appetite-boosting medications.
Hear when a new Locally Advanced Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.